BRIEF published on 05/23/2025 at 12:25, 6 months 12 days ago IPConcept (Luxemburg) S.A. Discloses Position in Adriatic Metals Securities Disclosure Takeover Code Rule 8.3 Adriatic Metals IPConcept (Luxemburg) S.A. BAKERSTEEL GLOBAL FUNDS
BRIEF published on 05/23/2025 at 12:25, 6 months 12 days ago IPConcept (Luxembourg) SA dévoile sa position dans Adriatic Metals Divulgation Des Valeurs Mobilières Règle 8.3 Du Code Des OPA Métaux De L'Adriatique IPConcept (Luxembourg) SA FONDS MONDIAUX BAKERSTEEL
PRESS RELEASE published on 05/23/2025 at 12:20, 6 months 12 days ago Form 8.3 - IPConcept (Luxemburg) S.A.: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE BAKERSTEEL GLOBAL FUNDS SICAV discloses a 1.22% stake in ADRIATIC METALS PLC CDIS (AU0000004772) as of May 22, 2025 Disclosure Stake 1.22% BAKERSTEEL GLOBAL FUNDS SICAV ADRIATIC METALS PLC CDIS
Published on 12/05/2025 at 02:35, 4 hours 5 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 40 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 35 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 40 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 25 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
